Edgewood Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
MAM
DIG
Edgewood Management's ARMP Position: Q2 2026 in Review
Edgewood Management reduced its Armata Pharmaceuticals (ARMP) stake by 20% in Q2 2026, selling an estimated $183K and leaving 80,000 shares worth $518K. The position accounts for 0.01% of the portfolio, ranked #74.
Edgewood Management first reported a position in ARMP in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.02M in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.
- Edgewood Management held 80,000 shares of Armata Pharmaceuticals worth $518K as of Q2 2026.
- Edgewood Management sold 20,000 Armata Pharmaceuticals shares in Q2 2026, an estimated $183K.
- Armata Pharmaceuticals made up 0.01% of Edgewood Management's portfolio in Q2 2026, its #74 holding.
- Edgewood Management first reported a position in Armata Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
- Edgewood Management's Armata Pharmaceuticals position peaked at $1.02M in Q1 2026.
- 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.
Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.